Gene Editing Might Alter Our DNA. It Might Destroy Our Humanity, Too.
By Mark Buchanan,
Bloomberg
| 11. 25. 2019
Biologists recently revealed a new form of the gene-editing tool known as Crispr that allows researchers to make precise changes to almost any element of DNA, permanently altering cellular biochemistry. It could help treat tens of thousands of diseases linked to variations in a single gene and lead to the creation of better antibiotics.
The latest development, called prime editing, is more accurate than older Crispr methods, which sometimes alter genomic DNA in the wrong places. The new method will be a boon to the least contentious kind of gene editing — gene therapy — which introduces genetic changes only within the body’s somatic or nonreproductive cells. One such method is already in clinical trials to treat Huntington’s disease, in which a genetic mutation leads to production of an abnormal protein in brain cells.
As gene-editing technology races ahead, scientists are agonizing over ethical issues. How, for example, can they ensure that treatments don’t cause more problems than they fix? Some genetic variants that seem clearly beneficial — lowering the risk of heart disease, for example — could have other...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...